White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs
Novo Nordisk Says White House Obesity Plan Is Step in Right Direction -- Interview
European Equities Traded in the US as American Depositary Decline in Tuesday Trading
Express News | Benzinga Market Summary: Best Buy And Kohl's Cut Outlook, Biden Admin Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs, PResident-Elect Trump Threatens Tariffs On China, Canada And Mexico
Sector Update: Health Care Stocks Mixed Premarket Tuesday
Amgen (AMGN.US) released mid-term data on the weight loss therapy MariTide, showing weight loss effects comparable to Novo Nordisk.
Amgen announced on Tuesday that its experimental weight loss therapy MariTide achieved significant results in Phase 2 trials.
